Global Alcohol Use Disorder Treatment Market Highlights Over 2022 – 2030
The global alcohol use disorder treatment market is estimated to garner significant revenue by growing at a notable CAGR over the forecast period, i.e., 2022 – 2030. The growth of the market is attributed to high prevalence of alcohol use worldwide. According to The World Bank, global average alcohol consumption per capita was projected to be 6.18 litres of pure alcohol in 2018. Moreover, increasing awareness regarding alcohol use disorder, and growing number of rehabilitation facilities are further fostering the growth of the market.
Get more information on this report: Download Sample PDF
Alcohol use disorder (AUD) is a medical condition where there is compulsive intake of alcohol that is characterized by an impaired ability to stop or control. AUD is considered a chronic brain disorder with adverse social, occupational, and health consequences. According to the WHO, in the age group 15 to 49 years, alcohol was the leading risk factor for premature mortality and disability, in 2018, and accounted for 10% of all deaths in the age group. According to Our World in Data, alcohol consumption caused 2.84 million premature deaths globally in 2017.
Alcohol Use Disorder (AUD) Epidemiology
The epidemiology section of the report covers detailed understanding on market overview in 8 major markets, i.e., the United States, Germany, U.K., France, Italy, Spain, Japan, and China comprising research analysis on drug pipeline, unmet needs, R&D expenditure, marketed products, and key players among other approaches pertaining to the treatment. The market in these regions crossed USD 6400 Million in revenue in 2020. Overall, around 88 million people are currently suffering from AUD, wherein, 6.5 million people are seeking treatment and the drug treated pool comprised of 3.2 million. In the U.S. alone, the alcohol treatment is estimated to be a ~USD 35 Billion/ year market as there are approximately 35 million people with AUD each year, out of which, only 8% get treated. Around 15 million of the people aged 12 and above had AUD in the United States in 2019. According to the CDC (Centers for Disease Control and Prevention), the alcohol-related deaths every year account to 95,000. The majority of the people with undiagnosed AUD are estimated to create huge market opportunities for drugs required to treat patients. This is one of the major factors, based on which, the market in these regions is estimated to witness a 2.1x growth from 2020 to 2030 and touch USD 13,189.5 Million in 2030.
The prevailing drugs in these markets are Antabuse (disulfiram), Vivitrol (naltrexone), Revia (naltrexone), Campral (acomprosate), and Selincro (nalmefene), where the disulfiram, naltrexone, and acomprosate are approved by the FDA, whereas, the nalmefene (available in Europe and Japan) is marketed outside of the U.S. However, there are challenges related to treatment such as stigma associated with alcoholism and lack of training in the utilization of FDA-approved options among others which might act as barriers to the growth of the market. Moreover, there are 12 molecules in pipeline from major players, out of them, 6 are in phase-2; and one in phase-3 from Adial Pharmaceuticals where clinical analysis suggests the likely approval of this molecule. The prominent key players in the market in these regions are Lundbeck, Odyssey Pharmaceuticals Inc., Merck, Sanofi, and Alkermes
Global Alcohol Use Disorder Treatment Market Segmentation Synopsis
The market is segmented by disorder type into alcohol abuse, alcohol dependence, alcohol addiction, and alcoholism, out of which, the alcohol abuse segment is expected to hold the largest market share over the forecast period owing to rising incidences of alcohol and substance abuse on the back of illegal sale of alcohol. Alcohol dependence segment is anticipated to witness highest growth owing to increasing alcohol dependency, especially among the younger population, leading to abuse.
On the basis of treatment type, the market is segmented into medicinal, therapy, multidisciplinary treatment, and others, out of which, the therapy segment is estimated to hold the largest market share owing to the availability of numerous types of therapies to manage AUD and high preference for therapies to avoid subsequent side effect on health. The multidisciplinary treatment segment is anticipated to witness rapid growth over the forecast period owing to its high and fast effectiveness on both mental and physical health.
Major Macro-Economic Indicators Impacting the Market Growth
According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.
Global Alcohol Use Disorder Treatment Market Regional Synopsis
Geographically, the global alcohol use disorder treatment market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. North America is expected to hold the largest market share owing to high prevalence of psychoactive substance abuse, with the U.S. leading the market in the region. Nearly 15 million people in the United States, over the age of 12, had AUD in 2019, which was reported to be 18 million in 2021. This region has the most extensive de-addiction and rehabilitation facilities that is expected to boost the market growth.
North America is closely followed by Europe region which is largely driven by countries such as Germany, Ireland, Russia, Poland, and Belgium owing to high alcohol consumption. As per European Commission, over 8% of the adult population in Europe consumed alcohol daily in 2019.
Asia-Pacific region is projected to witness growth at the highest rate over the forecast period owing to changing lifestyle, increasing disposable income, and higher younger population, especially in countries such as India.
Get more information on this report: Download Sample PDF
The global alcohol use disorder treatment market is further classified on the basis of region as follows:
- North America (U.S. & Canada) Market size, Y-O-Y Growth, Market Players Analysis & Opportunity Outlook
- Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
- Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook
- Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
- Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook
Market Segmentation
Our in-depth analysis of the global alcohol use disorder treatment market includes the following segments:
By Disorder Type
- Alcohol Abuse
- Alcohol Dependence
- Alcohol Addiction
- Alcoholism
By Treatment Type
- Medication
- Therapy
- Multidisciplinary Treatment
- Others
Growth Drivers
- High prevalence of alcohol use worldwide
- Increasing awareness regarding alcohol use disorder
- Growing number of rehabilitation facilities
Challenges
- Growing activities of illegal production and selling of psychoactive substances
Top Featured Companies Dominating the Market
- Alkermes
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Teva Pharmaceutical Industries Ltd.
- BioCorRx, Inc.
- Adial Pharmaceuticals
- ADDEX THERAPEUTICS
- Kinnov Therapeutics
- Opiant Pharmaceuticals
- Ethypharm
- Omeros Corporation
- Montisera Ltd.
